Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance coverage has fueled a risky but growing “gray” market for purchasing active ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.